Growth Metrics

Baxter International (BAX) Common Equity (2016 - 2025)

Baxter International (BAX) has disclosed Common Equity for 17 consecutive years, with $6.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 12.74% to $6.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 billion, a 12.74% decrease, with the full-year FY2025 number at $6.1 billion, down 12.74% from a year prior.
  • Common Equity was $6.1 billion for Q4 2025 at Baxter International, down from $7.2 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $9.1 billion in Q4 2021 to a low of $5.6 billion in Q3 2022.
  • A 5-year average of $7.6 billion and a median of $7.8 billion in 2024 define the central range for Common Equity.
  • Biggest YoY gain for Common Equity was 46.37% in 2023; the steepest drop was 36.75% in 2023.
  • Baxter International's Common Equity stood at $9.1 billion in 2021, then plummeted by 35.37% to $5.9 billion in 2022, then surged by 43.65% to $8.5 billion in 2023, then dropped by 17.05% to $7.0 billion in 2024, then dropped by 12.74% to $6.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BAX's Common Equity are $6.1 billion (Q4 2025), $7.2 billion (Q3 2025), and $7.3 billion (Q2 2025).